ask="19.99"
ask_size="300"
average_daily_volume="2935"
bid="9.02"
bid_size="200"
book_value="0.17"
change="-0.25"
change_from_200_day_moving_average="-1.01"
change_from_50_day_moving_average="-0.23"
change_from_52_week_high="-4.03"
change_From_52_week_low="11.76"
change_in_percent="-1.24%"
close="19.95"
dividend_pay_date="1/3/2017"
dividend_per_share="2.62"
dividend_yield="13.18"
earnings_per_share="-0.20"
ebitda="-41.64M"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="N/A"
ex_dividend_date="12/14/2016"
float_shares="229462000"
high="20.05"
high_52_weeks="23.98"
last_trade_date="1/4/2017"
last_trade_price="19.95"
last_trade_size="100"
last_trade_time="2:00pm"
low="19.90"
low_52_weeks="8.19"
market_capitalization="5.13B"
moving_average_200_day="20.96"
moving_average_50_day="20.18"
name="Peregrine Pharmaceuticals Inc. "
notes="N/A"
one_year_target_price="N/A"
open="19.90"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-4.81%"
percent_change_from_50_day_moving_average="-1.15%"
percent_change_from_52_week_high="-16.79%"
percent_change_from_52_week_low="+143.59%"
previous_close="20.20"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="120.24"
price_per_sales="95.36"
revenue="54.47M"
shares_outstanding="257141000"
short_ratio="0.00"
stock_exchange="NCM"
symbol="PPHMP"
volume="901"
weeks_range_52="8.19 - 23.98"
